Exploring alpha7-nicotinic acetylcholine receptors (a7R) as a type 1 diabetes therapeutic target
Fitzpatrick, Ryan
Fitzpatrick, Ryan
Citations
Altmetric:
License
License
Abstract
Type 1 diabetes involves the immune-mediated destruction of pancreatic ß-cells, the body's sole source of insulin. Besides insulin and its formulations, no widely accessible treatments or preventative therapies are available. Based on our prior animal studies, systemic α7R modulation may counter autoimmune diabetes progression by reducing ß-cell inflammation and restoring function. No human safe α7R compounds have yet been tested for ß-cell survival activity. Here we show that the α7R partial agonist GTS-21 exhibits both STAT3-dependent anti-inflammatory activity and CREB/Akt-driven survival signaling in rat INS-1 cells. Thus, GTS-21 may be suitable for further testing for anti-diabetes activity in mouse models
Description
Date
2023-01-01
Student Status
Undergraduate
Journal Title
Journal ISSN
Volume Title
Type of presentation
Creative Presentation
Collections
Research Projects
Organizational Units
Journal Issue
Citation
DOI
Advisor(s)
Department
Program/Major
Biochemistry
College/School
College of Arts and Sciences
Organization
item.page.researchcategory
Arts & Humanities